• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

文拉法辛联合阿戈美拉汀治疗伴有自杀行为的强迫症患者

Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.

作者信息

Signorelli Maria S, Concerto Carmen, Battaglia Eliana, Costanzo Maria C, Battaglia Fortunato, Aguglia Eugenio

机构信息

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Department of Interprofessional Health Sciences and Health Administration, Seton Hall University, South Orange, NJ, USA.

出版信息

SAGE Open Med Case Rep. 2014 Dec 4;2:2050313X14561778. doi: 10.1177/2050313X14561778. eCollection 2014.

DOI:10.1177/2050313X14561778
PMID:27489668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4857369/
Abstract

Obsessive-compulsive disorder is a chronic and disabling condition that often proves to be treatment resistant. Of the patients suffering from obsessive-compulsive disorder, 10%-27% may attempt suicide at least once in their life. We report the case of a patient who presented severe obsessive-compulsive disorder symptoms and attempted suicide ingesting 25 tablets of fluoxetine (20 mg). The patient was treated with venlafaxine and agomelatine and showed improvement of obsessive symptoms and suicidal ideation. Future studies are needed to investigate this treatment regime in large cohorts of obsessive-compulsive disorder patients with suicidal ideation.

摘要

强迫症是一种慢性致残性疾病,往往难以治疗。在患有强迫症的患者中,10% - 27%的人一生中可能至少尝试过一次自杀。我们报告了一例患者,该患者出现严重的强迫症症状,并吞服25片氟西汀(20毫克)企图自杀。该患者接受了文拉法辛和阿戈美拉汀治疗,强迫症状和自杀观念有所改善。未来需要开展研究,在大量有自杀观念的强迫症患者队列中调查这种治疗方案。

相似文献

1
Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.文拉法辛联合阿戈美拉汀治疗伴有自杀行为的强迫症患者
SAGE Open Med Case Rep. 2014 Dec 4;2:2050313X14561778. doi: 10.1177/2050313X14561778. eCollection 2014.
2
Alexithymia and perfectionism traits are associated with suicidal risk in patients with obsessive-compulsive disorder.述情障碍和完美主义特质与强迫症患者的自杀风险相关。
J Affect Disord. 2016 Mar 1;192:50-5. doi: 10.1016/j.jad.2015.12.018. Epub 2015 Dec 17.
3
Early maladaptive schemas and suicidal risk in an Iranian sample of patients with obsessive-compulsive disorder.早期适应不良模式与伊朗强迫症患者自杀风险的关系
Psychiatry Res. 2017 Sep;255:441-448. doi: 10.1016/j.psychres.2017.06.080. Epub 2017 Jun 27.
4
The relation of childhood trauma to suicide ideation in patients suffering from obsessive-compulsive disorder with lifetime suicide attempts.童年创伤与有自杀未遂史的强迫症患者自杀意念的关系。
Psychiatry Res. 2017 Sep;255:139-145. doi: 10.1016/j.psychres.2017.05.032. Epub 2017 May 20.
5
Suicidality in Subjects With Anxiety or Obsessive-Compulsive and Related Disorders: Recent Advances.焦虑或强迫症及相关障碍患者的自杀倾向:最新进展。
Curr Psychiatry Rep. 2018 Mar 28;20(4):26. doi: 10.1007/s11920-018-0885-z.
6
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.儿科抗抑郁治疗中的临床反应以及报告的自杀意念和自杀未遂风险:一项随机对照试验的荟萃分析
JAMA. 2007 Apr 18;297(15):1683-96. doi: 10.1001/jama.297.15.1683.
7
Suicidal behavior in obsessive-compulsive disorder.强迫症中的自杀行为。
J Clin Psychiatry. 2007 Nov;68(11):1741-50. doi: 10.4088/jcp.v68n1114.
8
Depression and risk of suicide in patients with obsessive-compulsive disorder: A hospital-based study.强迫症患者的抑郁与自杀风险:一项基于医院的研究。
Ind Psychiatry J. 2016 Jul-Dec;25(2):166-170. doi: 10.4103/ipj.ipj_63_16.
9
The suicidality continuum in a large sample of obsessive-compulsive disorder (OCD) patients.大量强迫症(OCD)患者样本中的自杀倾向连续体
Eur Psychiatry. 2016 Oct;38:1-7. doi: 10.1016/j.eurpsy.2016.05.003. Epub 2016 Sep 6.
10
Suicidal and death ideation among adults with obsessive-compulsive disorder presenting for intensive intervention.寻求强化干预的强迫症成年患者中的自杀及死亡观念
Ann Clin Psychiatry. 2017 Feb;29(1):46-53.

引用本文的文献

1
A Systematic Review on the Effect of Nutraceuticals on Antidepressant-Induced Sexual Dysfunctions: From Basic Principles to Clinical Applications.营养保健品对抗抑郁药所致性功能障碍影响的系统评价:从基本原理到临床应用
Curr Issues Mol Biol. 2022 Jul 25;44(8):3335-3350. doi: 10.3390/cimb44080230.
2
What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?在临床实践中,阿戈美拉汀与其他抗抑郁药的哪些联合用药方案在治疗重度抑郁症或焦虑症时可能会取得成功?
Ther Adv Psychopharmacol. 2019 Jul 7;9:2045125319855206. doi: 10.1177/2045125319855206. eCollection 2019.

本文引用的文献

1
Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.阿戈美拉汀治疗广泛性焦虑障碍的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):885-92. doi: 10.1517/17425255.2014.907794. Epub 2014 Apr 9.
2
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.褪黑素能系统在情绪和焦虑障碍中的作用及阿戈美拉汀的角色:对临床实践的启示
Int J Mol Sci. 2013 Jun 13;14(6):12458-83. doi: 10.3390/ijms140612458.
3
Quality of life in obsessive compulsive disorder.强迫症患者的生活质量。
CNS Spectr. 2013 Feb;18(1):21-33. doi: 10.1017/S1092852912000697. Epub 2013 Jan 2.
4
Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report.阿戈美拉汀增强艾司西酞普兰治疗难治性强迫症:一例报告
Case Rep Psychiatry. 2012;2012:642752. doi: 10.1155/2012/642752. Epub 2012 Oct 9.
5
Role of melatonin in mood disorders and the antidepressant effects of agomelatine.褪黑素在心境障碍中的作用和阿戈美拉汀的抗抑郁作用。
Expert Opin Investig Drugs. 2012 Oct;21(10):1503-22. doi: 10.1517/13543784.2012.711314. Epub 2012 Aug 9.
6
Circadian rhythms in obsessive-compulsive disorder.强迫症中的昼夜节律。
J Neural Transm (Vienna). 2012 Oct;119(10):1077-83. doi: 10.1007/s00702-012-0805-z. Epub 2012 Apr 28.
7
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.一例采用阿戈美拉汀单药治疗成功的强迫症病例。
J Clin Psychopharmacol. 2012 Apr;32(2):289-90. doi: 10.1097/JCP.0b013e318249298c.
8
Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD.昼夜节律紊乱在强迫症(OCD)中重要吗?一例阿戈美拉汀成功增效治疗强迫症的病例。
Clin Neuropharmacol. 2011 Jul-Aug;34(4):139-40. doi: 10.1097/WNF.0b013e318223421f.
9
Pharmacological management of treatment-resistant obsessive-compulsive disorder.治疗抵抗性强迫症的药物治疗管理。
CNS Drugs. 2011 Jul;25(7):585-96. doi: 10.2165/11587860-000000000-00000.
10
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.系统、更新的抗抑郁药阿戈美拉汀综述,重点关注其对褪黑素能的调节。
Curr Neuropharmacol. 2010 Sep;8(3):287-304. doi: 10.2174/157015910792246227.